Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

inpharm co. d.o.o. banja luka - ibrutinib - kapsula, tvrda - 140 mg/1 kapsula - 1 kapsula, tvrda sadrži: 140 mg ibrutiniba

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

inpharm co. d.o.o. banja luka - ibrutinib - kapsula, tvrda - 140 mg/1 kapsula - 1 kapsula, tvrda sadrži: 140 mg ibrutiniba

Europska Unija - hrvatski - EMA (European Medicines Agency)

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

inpharm co. d.o.o. banja luka - ibrutinib - kapsula, tvrda - 140 mg/1 kapsula - 1 kapsula, tvrda sadrži: 140 mg ibrutiniba

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

inpharm co. d.o.o. banja luka - ibrutinib - kapsula, tvrda - 140 mg/1 kapsula - 1 kapsula, tvrda sadrži: 140 mg ibrutiniba

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

abbvie d.o.o. - ritonavir - filmom obložena tableta - 100 mg/1 tableta - 1 filmom obložena tableta sadrži: 100 mg ritonavir

Europska Unija - hrvatski - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sandoz d.o.o., maksimirska 120, zagreb - lopinavirum, ritonavirum - filmom obložena tableta - 200 mg + 50 mg - urbroj: svaka filmom obložena tableta sadrži 200 mg lopinavira i 50 mg ritonavira

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

pfizer croatia d.o.o., slavonska avenija 6, zagreb, hrvatska - flukonazol - prašak za oralnu suspenziju - 10 mg/ml - urbroj: 1 ml pripremljene suspenzije sadrži 10 mg flukonazola

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

pfizer croatia d.o.o., slavonska avenija 6, zagreb - flukonazol - kapsula, tvrda - 100 mg - urbroj: jedna tvrda kapsula sadrži 100 mg flukonazola